Dipyridamole decreases dialysis risk and improves survival in patients with pre-dialysis advanced chronic kidney disease

INTRODUCTION: Dipyridamole decreases proteinuria and improves renal function progression in patients with glomerular disease through its inhibition of platelet activation and enhanced nitric oxide expression. Few studies have evaluated the effects of dipyridamole on renal outcome or survival in CKD...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Oncotarget
Autors principals: Kuo, Ko-Lin, Hung, Szu-Chun, Tseng, Wei-Cheng, Liu, Jia-Sin, Lin, Ming-Huang, Hsu, Chih-Cheng, Tarng, Der-Cherng
Format: Artigo
Idioma:Inglês
Publicat: Impact Journals LLC 2017
Matèries:
Meta-Analysis
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5797055/
https://ncbi.nlm.nih.gov/pubmed/29435184
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.19850
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars